Joshua Regal

MD, PhD, FRCPC
Radiation Oncology

Specializing In:

Accelerated Partial Breast Irradiation (APBI) Intensity-Modulated Radiation Therapy (IMRT) Volumetric modulated arc therapy (VMAT) Ductal Carcinoma In-Situ Prone-positioning Radiation Delivery Deep-Inspiration Breath Hold (DIBH) Multi-modality treatment planning (PET, 4D CT, MRI) Image-guided radiotherapy (IGRT) Stereotactic Body Radiation Therapy (SBRT)/Stereotactic Ablative Radiotherapy (SABR) Prostate external beam radiotherapy Palliative Radiotherapy Radiotherapy for benign conditions Precision medicine

Research Interests:

Personalized oncogenomics Genetic interactions, particularly as they pertain to synthetic lethality and/or conditional lethality DNA damage response Tumor microenvironment Single cell/nucleus, spatial, and bulk omics Data science and artificial intelligence to personalize medical decision making

About Joshua Regal

Positions

Roswell Park Comprehensive Cancer Center
  • Assistant Professor of Oncology
  • Department of Radiation Medicine

Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo

  • Assistant Professor of Radiation Oncology

Background

Education and Training:

  • 2009-2013 - PhD - Molecular and Cellular Pathology, University of Michigan; Ann Arbor, MI
  • 2007-2014 - MD - University of Michigan, Ann Arbor, MI
  • 2001-2005 - BS - Molecular Synthesis and Molecular Biology, University of California, San Diego, La Jolla, CA

Residency:

  • 2018-2022 - Radiation Oncology, Duke University, Durham, NC
  • 2017-2018 - Internal Medicine, University of California, Irvine, Irvine, CA

Fellowship:

  • 2022-2023 - Postdoctoral fellowship, Radiation Oncology, Duke University, Durham, NC
  • 2015-2017 - Postdoctoral fellowship, Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada
  • 2005-2007 - Postbaccalaureate fellowship, Hematopoiesis and Bone Marrow Failure, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Board Certification:

  • Royal College of Physicians and Surgeons of Canada

Professional Memberships:

  • Royal College of Physicians and Surgeons of Canada
  • American Society of Radiation Oncology
  • Canadian Association of Radiation Oncology
  • American Society of Clinical Oncology

Honors & Awards:

  • 2022 - Duke Radiation Oncology Resident Research Award
  • 2016-2018 - Ruth L. Kirschstein National Research Service Award
  • 2015 - Graduation with distinction in research, University of Michigan Medical School
  • 2010-2012 - University of Michigan Cancer Biology Training Grant Fellowship
  • 2010 - Best Talk Award, University of Michigan Medical Scientist Training Program Retreat
  • 2007-2014 - University of Michigan Medical Scientist Training Program Fellowship
  • 2005 - Summa Cum Laude, University of California, San Diego
  • 2005 - Phi Beta Kappa
  • 2005 - Department Honors in Molecular Synthesis, University of California, San Diego
  • 2005 - Highest Career GPA in Molecular Biology, University of California, San Diego
  • 2005 - Department of Chemistry and Biochemistry Harold C. Urey Award, University of California, San Diego

Publications

Full Publications list on PubMed

Tu KJ, Diplas BH, Regal JA, Waitkus MS, Pirozzi CJ, Reitman ZJ (2023). Mining cancer genomes for change-of-metabolic-function mutations. Commun Biol. 6(1):1143.

Mangoli A, Wu S, Liu HQ, Aksu M, Jain V, Foreman BE, Regal JA, Weidenhammer LB, Stewart CE, Guerra Garcia ME, Hocke E, Abramson K, Williams NT, Luo L, Deland K, Attardi L, Abe K, Hashizume R, Ashley DM, Becher OJ, Kirsch DG, Gregory SG, Reitman ZJ (2023). Ataxia-telangiectasia mutated ( Atm ) disruption sensitizes spatially-directed H3.3K27M/TP53 diffuse midline gliomas to radiation therapy. bioRxiv.

Tu KJ, Stewart CE, Hendrickson PG, Regal JA, Kim SY, Ashley DM, Waitkus MS, Reitman ZJ (2023). Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma. Oncogene. 42(44):3274-3286.

Regal JA, Guerra García ME, Jain V, Chandramohan V, Ashley DM, Gregory SG, Thompson EM, López GY, Reitman, ZJ (2023). Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population. Acta Neuropathol Commun. 11(1):50.

Stewart CE, Guerra García ME, Luo L, Williams NT, Ma Y, Regal JA, Sansone P, Oldham M, Deland K, Becher OJ, Kirsch DG, Reitman ZJ (2022). Atm inactivation does not radiosensitize a primary mouse model of Pten-deleted brainstem glioma. Cancers. 4(18):4506.